272 related articles for article (PubMed ID: 6436700)
1. Leuprolide versus diethylstilbestrol for metastatic prostate cancer.
Leuprolide Study Group
N Engl J Med; 1984 Nov; 311(20):1281-6. PubMed ID: 6436700
[TBL] [Abstract][Full Text] [Related]
2. Leuprolide versus diethylstilbestrol for previously untreated stage D2 prostate cancer. Results of a prospectively randomized trial.
Garnick MB
Urology; 1986 Jan; 27(1 Suppl):21-8. PubMed ID: 3079935
[TBL] [Abstract][Full Text] [Related]
3. Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate.
Sharifi R; Lee M; Ojeda L; Ray P; Stobnicki M; Guinan P
Urology; 1985 Aug; 26(2):117-24. PubMed ID: 3927551
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate.
Smith JA; Glode LM; Wettlaufer JN; Stein BS; Glass AG; Max DT; Anbar D; Jagst CL; Murphy GP
Urology; 1985 Feb; 25(2):106-14. PubMed ID: 3918369
[TBL] [Abstract][Full Text] [Related]
5. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract Suppl; 1985 Mar; 37():8-12, 20-4. PubMed ID: 3931665
[No Abstract] [Full Text] [Related]
6. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
Chang A; Yeap B; Davis T; Blum R; Hahn R; Khanna O; Fisher H; Rosenthal J; Witte R; Schinella R; Trump D
J Clin Oncol; 1996 Aug; 14(8):2250-7. PubMed ID: 8708714
[TBL] [Abstract][Full Text] [Related]
7. Luteinizing hormone-releasing hormone (LH-RH) analogs in treatment of prostatic cancer. Clinical perspective.
Smith JA
Urology; 1986 Jan; 27(1 Suppl):9-15. PubMed ID: 3079936
[TBL] [Abstract][Full Text] [Related]
8. DES lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostate.
Stein BS; Smith JA
Urology; 1985 Apr; 25(4):350-3. PubMed ID: 3920802
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of (D-Leu6)-des Gly-NH2 10-LHRH ethylamide against prostatic cancer.
Yamanaka H; Makino T; Yajima H; Saruki K; Shida K
Prostate; 1985; 6(1):27-34. PubMed ID: 3918298
[TBL] [Abstract][Full Text] [Related]
10. Management of metastatic prostatic cancer.
Paulson DF
Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
[TBL] [Abstract][Full Text] [Related]
11. Hormonal therapy for prostate cancer.
Torti FM
N Engl J Med; 1984 Nov; 311(20):1313-4. PubMed ID: 6436701
[No Abstract] [Full Text] [Related]
12. Leuprolide: a gonadotropin-releasing hormone analog for the palliative treatment of prostatic cancer.
Wojciechowski NJ; Carter CA; Skoutakis VA; Bess DT; Falbe WJ; Mickle TR
Drug Intell Clin Pharm; 1986 Oct; 20(10):746-51. PubMed ID: 2429815
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.
Crawford ED; Eisenberger MA; McLeod DG; Spaulding JT; Benson R; Dorr FA; Blumenstein BA; Davis MA; Goodman PJ
N Engl J Med; 1989 Aug; 321(7):419-24. PubMed ID: 2503724
[TBL] [Abstract][Full Text] [Related]
14. Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer.
Harvey HA; Lipton A; Max DT; Pearlman HG; Diaz-Perches R; de la Garza J
J Clin Oncol; 1985 Aug; 3(8):1068-72. PubMed ID: 3926958
[TBL] [Abstract][Full Text] [Related]
15. Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group.
Sharifi R; Soloway M
J Urol; 1990 Jan; 143(1):68-71. PubMed ID: 2104638
[TBL] [Abstract][Full Text] [Related]
16. Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Garnick MB; Glode LM; Smith JA; Max DT
Br J Clin Pract; 1985 Feb; 39(2):73-6. PubMed ID: 3921047
[No Abstract] [Full Text] [Related]
17. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
Santen RJ; Warner B
Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of (D-Leu6)-des Gly-NH2(10)-LHRH ethylamide against prostatic cancer].
Yamanaka H; Makino T; Kumasaka F; Shida K
Hinyokika Kiyo; 1984 Apr; 30(4):545-60. PubMed ID: 6435416
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment testosterone levels: significance in androgen deprivation therapy.
Hickey D; Todd B; Soloway MS
J Urol; 1986 Nov; 136(5):1038-40. PubMed ID: 3095566
[TBL] [Abstract][Full Text] [Related]
20. Androgen suppression by a gonadotropin releasing hormone analogue in patients with metastatic carcinoma of the prostate.
Smith JA
J Urol; 1984 Jun; 131(6):1110-2. PubMed ID: 6427478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
